| 2841 |
GLIPITA 50 |
SITAGLIPTIN PHOSPHATE MONOHYDRATE BP 64.250 MG EQ.TO SITAGLIPTIN 50 MG |
TABLET |
ALU-ALU BLISTER |
AS AN ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL IN PATIENTS WITH TYPE II DIABETES MELLITUS |
NULL |
VIMPEX (LAO) CO.,LTD |
BEXIMCO PHARMACEUTICALS LTD |
BANGLADESH |
CERTIFICATE RELEASED |
10 I 4610/18 |
08-JAN-2024 |
07-JAN-2027 |
View |
| 2842 |
GLIPITA M 50 /1000 |
SITAGLIPTIN PHOSPHATE MONOHYDRATE BP 64.250 MG EQ. TO SITAGLIPTIN 50 MG, METFORMIN HYDROCHLORIDE BP 1000 MG |
TABLET |
ALU-PVDC BLISTER |
AS AN ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIA CONTROL IN ADULTS WITH TYPE 2 DIABETES MELLITUS |
NULL |
VIMPEX (LAO) CO.,LTD |
BEXIMCO PHARMACEUTICALS LTD |
BANGLADESH |
CERTIFICATE RELEASED |
10 I 4613/18 |
08-JAN-2024 |
07-JAN-2027 |
View |
| 2843 |
GLIPITA M 50/500 |
SITAGLIPTIN PHOSPHATE MONOHYDRATE BP 64.250 MG EQ. TO SITAGLIPTIN 50 MG, METFORMIN HYDROCHLORIDE BP 500 MG |
TABLET |
ALU-PVDC BLISTER |
AS AN ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIA CONTROL IN ADULTS WITH TYPE 2 DIABETES MELLITUS |
NULL |
VIMPEX (LAO) CO.,LTD |
BEXIMCO PHARMACEUTICALS LTD |
BANGLADESH |
CERTIFICATE RELEASED |
10 I 4612/18 |
08-JAN-2024 |
07-JAN-2027 |
View |
| 2844 |
HEALIT SKIN OINTMENT |
BACITRACIN B.P 500 UNITS, POLYMYXIN B SULPHATE B.P 5000 UNITS, NEOMYCIN BASE (AS NEOMYCIN SULPHATE BP) 3.5 MG, LIDOCAINE BP 40 MG |
OINTMENT |
TUBE |
TO PREVENT INFECTION AND IMMEDIATE RELIEF IN SURGICAL INCISIONS, ACCIDENTAL CUTS, BURNS, SCRATCHES, ABRASIONS AND OTHER PRIMARY INFECTED DERMATOSIS LIKE CELLULITIS, FOLLICULITIS, FURUNCULOSIS, CARBUNCLE AND IMPETIGO |
NULL |
VIMPEX (LAO) CO.,LTD |
ATCO LABORATORIES LIMITED |
PAKISTAN |
CERTIFICATE RELEASED |
12 I 5356/22 |
30-DEC-2022 |
29-DEC-2025 |
View |
| 2845 |
HEXIGOLD MOUTHWASH |
CHLORHEXIDINE GLUCONATE 0.2% W/V |
ORAL SOLUTION |
BOTTLE |
TO PREVENT AND TREAT GINGIVITIS, TO MAINTAIN GOOD ORAL HYGIENE AND AVOID BAD BREATH, PREVENTIONA OF PLAQUE IN ABSENCE OF BRUSHING, TREATMENT OF ORAL CANDIDIASIS, CONTROLLING SECONDARY BACTERIAL INFECTION FOR ULCERS, AID IN TREATMENT OF MOUTH AND THROAT INFECTION. |
NULL |
VIMPEX (LAO) CO.,LTD |
G.S.PHARMBUTOR PRIVATE LIMITED |
INDIA |
CERTIFICATE RELEASED |
09 I 5813/24 |
25-SEP-2024 |
24-SEP-2029 |
View |
| 2846 |
IBUKANT F-400 |
IBUPROFEN BP 400 MG |
TABLET |
ALU-PVC BLISTER |
FOR THE SYMPTOMATIC TREATMENT OF PAINFUL CONDITIONS OF MILD TO MODERATE AND/OR FEVER. |
NULL |
VIMPEX (LAO) CO.,LTD |
S KANT HEALTHCARE LTD |
INDIA |
CERTIFICATE RELEASED |
01 I 5687/24 |
06-FEB-2024 |
05-FEB-2027 |
View |
| 2847 |
INDICONTIN |
INDAPAMIDE USP 1.5 MG |
CONTROLLED RELEASED TABLET |
ALU-PVC |
FOR THE TREATMENT OF ESSENTIAL HYPERTENSION |
NULL |
VIMPEX (LAO) CO.,LTD |
MODI-MUNDIPHARMA PRIVATE LTD |
INDIA |
CERTIFICATE RELEASED |
01 I 5382/23 |
23-Jan-2023 |
22-Jan-2026 |
View |
| 2848 |
INFORMET LA 500 TABLET |
METFORMIN HYDROCHLORIDE BP 500 MG |
TABLET |
ALU-PVC BLISTER STRIP |
AS AN ADJUNCT TO DIET TO LOWER BLOOD GLUCOSE ESPECIALLY IN OVERWEIGHT PATIENTS WITH NON-INSULIN DEPENDENT DIABETES MELLITUS OR TYPE 2 DIABETES MELLITUS WHOSE HYPERGLYCEMIA CAN NOT BE SATISFACTORILY MANAGED ON DIET ALONE. |
NULL |
VIMPEX (LAO) CO.,LTD |
BEXIMCO PHARMACEUTICALS LIMITED |
BANGLADESH |
CERTIFICATE RELEASED |
04 I 5723/24 |
08-APR-2024 |
07-APR-2027 |
View |
| 2849 |
KEFUCLAV 250 |
CEFUROXIME AXETIL USP 312.5 MG EQ.TO CEFUROXIME 250 MG, DILUTED POTASSIUM CLAVULANATE( WITH AVICEL) BP 148.81 MG EQ.TO CLAVULANIC ACID 62.5 MG |
FILM-COATED TABLETS |
ALU-ALU STRIP |
PHARYNGITIS/TONSILLITIS, ACUTE BACTERIAL OTITIS MEDIA, ACUTE BACTERIAL MAXILLARY SINUSITIS, ACUTE BACTERIAL EXACERBATIONS OF CHRONIC BRONCHITIS AND SECONDARY BACTERIAL INFECTIONS OF ACUTE BRONCHITIS, UNCOMPLICATED SKIN AND SKIN-STRUCTURE INFECTIONS, UNCOMPLICATED URINARY TRACT INFECTION, UNCOMPLICATED GONORRHEA. |
NULL |
VIMPEX (LAO) CO.,LTD |
ESKAYEF PHARMACEUTICALS LIMITED |
BANGLADESH |
CERTIFICATE RELEASED |
07 I 4523/18 |
07-JUL-2025 |
06-JUL-2030 |
View |
| 2850 |
KETOZ |
KETOCONAZOLE USP 200 MG |
TABLET |
ALU-PVC BLISTER |
TREATMENT OF SUPERFICIAL AND DEEP MYCOSES: SYSTEMIC MYCOTIC INFECTION SUCH AS SYSTEMIC CANDIDIASIS, CHRONIC AND RECURRENT VAGINAL CANDIDIASIS NOT RESPONDING TO TOPICAL TREATMENT, SERIOUS CHRONIC INFECTION OF THE SKIN, HAIR AND NAILS CAUSED BY SENSITIVE DERMATOPHYTES. |
NULL |
VIMPEX (LAO) CO.,LTD |
S KANT HEALTHCARE LTD |
INDIA |
CERTIFICATE RELEASED |
01 I 5688/24 |
06-FEB-2024 |
05-FEB-2027 |
View |
